The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats.
Schwabl P, Brusilovskaya K, Supper P, Bauer D, Königshofer P, Riedl F, Hayden H, Fuchs CD, Stift J, Oberhuber G, Aschauer S, Bonderman D, Gnad T, Pfeifer A, Uschner FE, Trebicka J, Rohr-Udilova N, Podesser BK, Peck-Radosavljevic M, Trauner M, Reiberger T.
Schwabl P, et al. Among authors: brusilovskaya k.
Sci Rep. 2018 Jun 19;8(1):9372. doi: 10.1038/s41598-018-27656-y.
Sci Rep. 2018.
PMID: 29921982
Free PMC article.